Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness

Ophthalmology

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness?

There are 1 clinical trial targeting Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness tracked by BioSniper.

What is the prevalence of Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness?

The estimated prevalence of Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness is approximately 5.0 per 100,000 population.

Deep-dive into Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness — Drugs in Development & Clinical Trials | BioSniper